In many neurological conditions, such as inflammation/degenerative diseases (Pampliega et al., 2011), hypoxic diseases (Jackman et al., 2010), epilepsy and brain tumors (Lewerenz et al., 2014), the transcription of the Slc7a11 gene is increased. This evidence concerns the gene SLC7A11 and brain neoplasm.